HAL vs LSTA · P/E 9.3, $19.05B cap vs rev $1.0M
Halliburton Company (HAL) versus Lisata Therapeutics Inc. (LSTA) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Lisata Therapeutics Inc. (LSTA) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported LSTA revenue for 2024-12-31 was $1.0M. Net income was -$20.0M. LSTA currently screens at market cap $31.7M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. LSTA currently screens at market cap $31.7M.
Not investment advice. Open the HAL and LSTA stock pages for the full models.
Not investment advice.